Literature DB >> 9072284

Estrogens, menopause, and coronary artery disease.

J M Sullivan1, L P Fowlkes.   

Abstract

The incidence of cardiovascular disease increases after menopause as women age. Estrogen-replacement therapy has been found to reduce cardiovascular risk by about 50% in over 30 observational studies. Part of the beneficial effect appears to be due to a reduction of LDL cholesterol and an increase in HDL cholesterol. Another important mechanism is related to the effect of estrogen on endothelial function. In making a decision to use estrogen-replacement therapy, the benefits must be weighed against the risks of endometrial and breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9072284     DOI: 10.1016/s0733-8651(05)70264-2

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  7 in total

Review 1.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

Review 2.  [Estrogens for prevention of coronary heart disease?].

Authors:  T Meinertz
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 3.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  Protective effects of estrogen in a rat model of age-related cataracts.

Authors:  R M Bigsby; H Cardenas; A Caperell-Grant; C J Grubbs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.

Authors:  D F Hargreaves; F Knox; R Swindell; C S Potten; N J Bundred
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

6.  Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.

Authors:  Anna Posadzy-Malaczynska; Katarzyna Rajpold; Lucyna Woznicka-Leskiewicz; Justyna Marcinkowska
Journal:  Clin Res Cardiol       Date:  2014-09-13       Impact factor: 5.460

7.  Modulation of coronary artery disease risk factors by menopausal status: A population based study among Iranian women (KERCADRStudy).

Authors:  Gholamreza Yousefzadeh; Fatemeh Mahdavi-Jafari; Mostafa Shokoohi; Hamid Najafipour; Ali-Akbar Haghdoost; Vida Modares-Nejad
Journal:  ARYA Atheroscler       Date:  2013-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.